Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Annexin A3 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement Annexin A3 dans WB et IHC. Il présente une réactivité avec des échantillons de Humain. Il a été cité dans 4+ publications.
N° du produit ABIN2716166
627,08 €
Plus frais de livraison 40,00 € et TVA
0.1 mL
Destination: France
Envoi sous 7 à 9 jours ouvrables

Aperçu rapide pour Annexin A3 anticorps (ABIN2716166)

Antigène

Voir toutes Annexin A3 (ANXA3) Anticorps
Annexin A3 (ANXA3)

Reactivité

  • 87
  • 29
  • 24
  • 6
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
Humain

Hôte

  • 78
  • 24
Souris

Clonalité

  • 78
  • 22
Monoclonal

Conjugué

  • 66
  • 13
  • 6
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Cet anticorp Annexin A3 est non-conjugé

Application

  • 77
  • 41
  • 24
  • 19
  • 13
  • 13
  • 10
  • 7
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)

Clone

1F11
  • Attributs du produit

    Homo sapiens annexin A3 (ANXA3)

    Purification

    Purified from mouse ascites fluids by affinity chromatography

    Immunogène

    Full length human recombinant protein of human ANXA3 (NP_005130) produced in HEK293T cell.

    Isotype

    IgG2b
  • Indications d'application

    WB 1:500~2000, IHC 1:150,

    Commentaires

    The concentration of the product may vary between diferrent lots.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5-1.0 mg/mL

    Buffer

    PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C
  • Wang, Li: "Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth." dans: Oncotarget, Vol. 7, Issue 52, pp. 86972-86984, (2018) (PubMed).

    Pan, Pan, Weng, Zhao, Zhang, Wang, Lv, Jiang, Zheng, Xia: "Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma." dans: Molecular carcinogenesis, Vol. 54, Issue 8, pp. 598-607, (2015) (PubMed).

    Pan, Pan, Wang, Weng, Zhao, Zheng, Zhang, Jiang, Lv, Tang, Li, He, Liu, Chen, Zhang, Xia: "Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells." dans: Stem cells (Dayton, Ohio), Vol. 33, Issue 2, pp. 354-66, (2015) (PubMed).

    Mercado, Kizawa, Ueda, Xiong, Kimura, Moses, Curtis, Ito, Barnes: "Activation of transcription factor Nrf2 signalling by the sphingosine kinase inhibitor SKI-II is mediated by the formation of Keap1 dimers." dans: PLoS ONE, Vol. 9, Issue 2, pp. e88168, (2014) (PubMed).

  • Antigène

    Annexin A3 (ANXA3)

    Autre désignation

    ANXA3

    Sujet

    This gene encodes a member of the annexin family. Members of this calcium-dependent phospholipid-binding protein family play a role in the regulation of cellular growth and in signal transduction pathways. This protein functions in the inhibition of phopholipase A2 and cleavage of inositol 1,2-cyclic phosphate to form inositol 1-phosphate. This protein may also play a role in anti-coagulation.

    Poids moléculaire

    36.2 kDa

    ID gène

    306

    NCBI Accession

    NM_005139

    HGNC

    306
Vous êtes ici:
Chat with us!